Anavex investors face Nov. 30 deadline to seek lead role

The complaint alleges that Anavex and other defendants lacked adequate internal controls and understated potential regulatory challenges linked to alleged misconduct by former CEO Christopher Missling. It further claims that statements about the company’s business, operations and prospects were materially false or misleading, or lacked a reasonable basis. The allegations have not been established in court. The lawsuit says investors suffered losses after the alleged truth reached the market.

Investors seeking information about joining the case can visit Rosen Law Firm’s case page, call Phillip Kim, Esq., at 866-767-3653, or email case@rosenlegal.com. The firm says investors may be eligible for compensation through a contingency-fee arrangement, with no out-of-pocket fees or costs.

No class has been certified. Until certification, investors are not represented by counsel unless they retain one, and they may choose their own lawyer or remain absent class members. The firm says an investor’s ability to share in a potential recovery does not depend on serving as lead plaintiff. The notice is attorney advertising; prior results do not guarantee a similar outcome.